Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COntrolled Interruption of Nucleos(t)Ide Analogue Treatment in Chronic Hepatitis B Infections

NCT04779970 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT04779970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04779970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COntrolled Interruption of Nucleos(t)Ide Analogue Treatment in Chronic Hepatitis B Infections
Lead sponsor
University Hospital, Antwerp
Phase
Not applicable
Overall status
Unknown status
Start date
July 28, 2021
Completion date
December 31, 2025
Enrollment
156 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b